Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
114,135
Sort by:
Substance Abuse Alcoholism Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Alcoholism Therapy Area Pipeline Report contains detailed information on the alcoholism drug pipeline. This report provides insight into the pipeline status of alcoholism drug...
January 2010
92 pages
Substance Abuse Antidote Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Antidote Therapy Area Pipeline Report contains detailed information on the antidote drug pipeline. This report provides insight into the pipeline status of antidote drugs by c...
January 2010
39 pages
Substance Abuse Poisoning Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Poisoning Therapy Area Pipeline Report contains detailed information on the poisoning drug pipeline. This report provides insight into the pipeline status of poisoning drugs b...
January 2010
159 pages
Women's Health Contraception Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Contraception Therapy Area Pipeline Report contains detailed information on the contraception drug pipeline. This report provides insight into the pipeline status of contracep...
January 2010
431 pages
Women's Health Dysmenorrhea Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Dysmenorrhea Therapy Area Pipeline Report contains detailed information on the dysmenorrhea drug pipeline. This report provides insight into the pipeline status of dysmenorrhe...
January 2010
72 pages
Women's Health Endometriosis Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Endometriosis Therapy Area Pipeline Report contains detailed information on the endometriosis drug pipeline. This report provides insight into the pipeline status of endometri...
January 2010
105 pages
Women's Health Infertility Therapy Area Pipeline Report
US$ 1,495.00
Life Science Analytics', Infertility Therapy Area Pipeline Report contains detailed information on the infertility drug pipeline. This report provides insight into the pipeline status of infertility d...
January 2010
164 pages
Analysis of Telemedicine Market
US$ 800.00
... rate and increasing health expenditure in emerging economies. However, the telemedicine market is also facing challenges like reimbursement by third party payers, ... the major market players with a discussion of their key business strategies. By combining SPSS Inc.’s data integration and analysis capabilities ...
January 2010
40 pages
Home Healthcare Market (2009-2014)
US$ 5,650.00
... years. Market Estimates and Forecast The report provides in-depth market estimates and forecasts for the global home healthcare market as follows: • Home Healthcare Equipment - Home therapeutic equipment (oxygen delivery systems, CPAP, nebulizers, ventilators, humidifiers, IV diagnostics, home dialysis, ostomy supplies, and others) - Home ...
January 2010
300 pages
Global Dental Consumables Market
US$ 5,650.00
... dental hand pieces, dental preventives, endodontics, and infection control products. This report provides an extensive analysis of the global dental consumables market, including current market size, market forecasts, market trend analysis, as well as a competitive analysis of the recent developments in the dental consumables market. The report also ...
January 2010
195 pages
Competitor Analysis: PSMA & PSA Targeted Therapy
US$ 180.00
... targeted therapy of prostate and other cancers. Prostate-specific antigen (PSA) was discovered more than 20 years ago and has become the ... PSA Targeted Therapy Corporate PSMA & PSA Targeted Therapy R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers ...
January 2010
18 pages
Competitor Analysis: Selective Estrogen Receptor Modulators
US$ 180.00
... Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. Index Selective Estrogen Receptor Modulators Corporate SERM R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise ...
January 2010
19 pages
U.S. Market for PACS and EMR 2010
US$ 7,495.00
... PACS was valued at almost $1.3 billion, representing an increase of 6.7% over 2007. This market encompasses large hospitals (500+ beds), medium hospitals (201-499 beds), ... ). This growth will be fuelled by the sales of PACS, mostly to the community and imaging center markets. Replacement–driven sales will fuel ...
December 2009
217 pages
Global Dental Industry: An Analysis
US$ 800.00
... have also impacted the growth of the industry positively. The main driving element for global dental equipment market is the advancement in technologies ... with 20% of market share. The report focuses on various aspects of dental industry including the market size and geographical segmentation of the market ...
December 2009
41 pages
Competitor Analysis: Neurotrophic Growth Factors
US$ 480.00
... disease Alzheimer's disease Multiple sclerosis Huntington's disease Ophthalmic diseases Various Corporate Neurotrophic Growth Factor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of ...
December 2009
38 pages
Competitor Analysis: Growth Factors for Bone, Dental, Cartilage and Tendon Repair
US$ 360.00
... engineered peptides, antibodies, small molecules or even plasmids. Among the growth stimulators are the BMPs, GDFs, PDGF, PTH receptor agonists, ... , Dental, Cartilage and Tendon Growth Factor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS ...
December 2009
42 pages
Competitor Analysis: Tissue Growth Factors
US$ 960.00
... description The present Competitive Intelligence Report about tissue growth factors provides a competitor evaluation in the field of molecules such as proteins, peptides ... as HGF, VEGF, TGF, NGF, GDF and quite a number of neurotrophic factors are under development. Apart from proteins as the classical drugs ...
December 2009
57 pages
Competitor Analysis: FGF-R Agonists and Antagonists
US$ 216.00
Product description The present Competitive Intelligence Report about TGF-R agonists and antagonists provides a competitor evaluation in the field of transforming growth factor receptor (TGF-R) or TG...
November 2009
20 pages
The Roche Intelligence Dossier
US$ 295.00
As the fourth largest pharmaceutical company in the world, with annual revenues of $43.9 billion, some of the most instantly recognisable drugs marketed and the kind of pipeline smaller companies only...
November 2009
48 pages
The GSK Intelligence Dossier
US$ 295.00
After two anemic years, GSK is ready to breathe new life.Despite intense competition from generics in the US, the company has finally reported a healthy growth in the third quarter of 2009.Now, eager...
November 2009
53 pages
The Novartis Intelligence Dossier
US$ 295.00
International censure over Novartis’ grave delays in supplying the H1N1 vaccine.Renewed criticism by an institutional investor for CEO Daniel Vasella’s substantial pay package and considerable power.A...
November 2009
55 pages
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
US$ 5,650.00
... and forecast This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the ... positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders. - Comprehensive market analysis for the following sectors: ...
November 2009
126 pages
